Guidelines for the management of menometrorrhagia, in women with and without pregnancy intention: Hierarchy of therapies;Hiérarchisation des stratégies thérapeutiques pour ménométrorragies avec ou sans désir de grossesse

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 37, Issue 8 SUPPL. 1, 2008, Pages

  Roman, H ^a   Loisel, C ^a   Puscasiu, L ^b   Sentilhes, L ^c   Marpeau, L ^a  

^a ROUEN UNIVERSITY HOSPITAL   (France)

^b UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

Adenomyosis; Atypical endometrial hyperplasia; Idiopathic endometrial hyperplasia; Menorrhagia; Myomas; Polyps

Indexed keywords

DANAZOL; GESTAGEN; LEVONORGESTREL; NONSTEROID ANTIINFLAMMATORY AGENT; TRANEXAMIC ACID; ESTROGEN; ORAL CONTRACEPTIVE AGENT;

ADENOMYOSIS; CURETTAGE; ENDOMETRIUM ABLATION; ENDOMETRIUM POLYP; HUMAN; HYSTERECTOMY; INTRAUTERINE CONTRACEPTIVE DEVICE; MENOMETRORRHAGIA; MENORRHAGIA; MYOMA; MYOMECTOMY; POLYPECTOMY; PRACTICE GUIDELINE; PREGNANCY; REVIEW; TREATMENT FAILURE; UTERINE ARTERY EMBOLIZATION; ADOLESCENT; ARTICLE; ARTIFICIAL EMBOLISM; DRUG EFFECT; ENDOMETRIUM HYPERPLASIA; FEMALE; FEMALE INFERTILITY; LEIOMYOMA; METRORRHAGIA; POLYP; UTERUS; UTERUS CANCER;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CONTRACEPTIVES, ORAL, HORMONAL; EMBOLIZATION, THERAPEUTIC; ENDOMETRIAL HYPERPLASIA; ESTROGENS; FEMALE; HUMANS; HYSTERECTOMY; INFERTILITY, FEMALE; LEIOMYOMA; LEVONORGESTREL; METRORRHAGIA; POLYPS; PREGNANCY; PROGESTINS; TRANEXAMIC ACID; UTERINE NEOPLASMS; UTERUS;

EID: 67749114108     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0368-2315(08)74781-1     Document Type: Article

References (82)

1. Lethaby AE, Cooke I, Rees M. Progesterone or progestogenreleasing intrauterine systems for heavy menstrual bleeding. Cochrane Database Syst Rev 2005;19(4):CD002126.
2. Stewart A, Cummins C, Gold L, Jordan R, Phillips W. The effectiveness of the levonorgestrel-releasing intrauterine system in menorrhagia: a systematic review. BJOG 2001;108(1):74-86. (Pubitemid 32102607)
3. NICE. Heavy menstrual bleeding: Royal College of Obstetricians and Gynaecologists; 2007.
4. Fraser IS, McCarron G . Randomized trial of 2 hormonal and 2 prostaglandin-inhibiting agents in women with a complaint of menorrhagia. Aust N Z J Obstet Gynaecol 1991;31(1):66-70.
5. Lethaby A, Irvine G, Cameron I. Cyclical progestogens for heavy menstrual bleeding. Cochrane Database Syst Rev 2008;23(1):CD001016. (Pubitemid 351807531)
6. Irvine GA, Campbell-Brown MB, Lumsden MA, Heikkila A, Walker JJ, Cameron IT. Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia. Br J Obstet Gynaecol 1998;105(6):592-598 (Pubitemid 28293475)
7. Said S, Omar K, Koetsawang S, et al. A multicentered phase III comparative clinical trial of depot-medroxyprogesterone acetate given three-monthly at doses of 100 mg or 150 mg: II. The comparison of bleeding patterns. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation Special Programme of Research, Development and Research Training in Human Reproduction. Contraception 1987;35(6):591-610.
8. Beaumont H, Augood C, Duckitt K, Lethaby A. Danazol for heavy menstrual bleeding. Cochrane Database Syst Rev 2007;18(3):CD001017.
9. Friedman AJ, Hoffman DI, Comite F, Browneller RW, Miller JD. Treatment of leiomyomata uteri with leuprolide acetate depot: a double-blind, placebo-controlled, multicenter study. The Leuprolide Study Group. Obstet Gynecol 1991;77(5):720-725
10. Coulter A, Kelland J, Peto V, Rees MC. Treating menorrhagia in primary care. An overview of drug trials and a survey of prescribing practice. Int J Technol Assess Health Care 1995;11(3):456-471
11. Preston JT, Cameron IT, Adams EJ, Smith SK. Comparative study of tranexamic acid and norethisterone in the treatment of ovulatory menorrhagia. Br J Obstet Gynaecol 1995;102(5):401-406
12. Lethaby A, Augood C, Duckitt K, Farquhar C. Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding. Cochrane Database Syst Rev 2007;17(4):CD000400. (Pubitemid 351805312)
13. Lindahl B, Alm P, Ferno M, Norgren A. Endometrial hyperplasia: a prospective randomized study of histopathology, tissue steroid receptors and plasma steroids after abrasio, with or without high dose gestagen treatment. Anticancer Res 1990;10(3):725-730 (Pubitemid 20237824)
14. Randall TC, Kurman RJ. Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40. Obstet Gynecol 1997;90(3):434-440
15. Agorastos T, Bontis J, Vakiani A, Vavilis D, Constantinidis T. Treatment of endometrial hyperplasias with gonadotropin-releasing hormone agonists: pathological, clinical, morphometric, and DNA-cytometric data. Gynecol Oncol 1997;65(1):102-114 (Pubitemid 27171560)
16. Wildemeersch D, Dhont M. Treatment of nonatypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine system. Am J Obstet Gynecol 2003;188(5):1297-1298 (Pubitemid 36589125)
17. Brechin S, Cameron ST, Paterson AM, Williams AR, Critchley HO. Intrauterine polyps-a cause of unscheduled bleeding in women using the levonorgestrel intrauterine system: case report. Hum Reprod 2000;15(3):650-652
18. Nathani F, Clark TJ. Uterine polypectomy in the management of abnormal uterine bleeding: A systematic review. J Minim Invasive Gynecol 2006;13(4):260-268 (Pubitemid 43975042)
19. Preutthipan S, Herabutya Y. Hysteroscopic polypectomy in 240 premenopausal and postmenopausal women. Fertil Steril 2005;83(3):705-709 (Pubitemid 40348584)
20. Henriquez DD, van Dongen H, Wolterbeek R, Jansen FW. Polypectomy in premenopausal women with abnormal uterine bleeding: effectiveness of hysteroscopic removal. J Minim Invasive Gynecol 2007;14(1):59-63. (Pubitemid 46049105)
21. Gebauer G, Hafner A, Siebzehnrubl E, Lang N. Role of hysteroscopy in detection and extraction of endometrial polyps: results of a prospective study. Am J Obstet Gynecol 2001;184(2):59-63. (Pubitemid 32141643)
22. Liberis V, Dafopoulos K, Tsikouras P, et al. Removal of endometrial polyps by use of grasping forceps and curettage after diagnostic hysteroscopy. Clin Exp Obstet Gynecol 2003;30(1):29-31. (Pubitemid 36396680)
23. Carlson KJ, Miller BA, Fowler FJ, Jr. The Maine Women's Health Study: II. Outcomes of nonsurgical management of leiomyomas, abnormal bleeding, and chronic pelvic pain. Obstet Gynecol 1994;83(4):566-572
24. Grigorieva V, Chen-Mok M, Tarasova M, Mikhailov A. Use of a levonorgestrel-releasing intrauterine system to treat bleeding related to uterine leiomyomas. Fertil Steril 2003;79(5):1194-1198 (Pubitemid 36547859)
25. Venkatachalam S, Bagratee JS, Moodley J. Medical management of uterine fibroids with medroxyprogesterone acetate (Depo Provera): a pilot study. J Obstet Gynaecol 2004;24(7):798-800. (Pubitemid 39643463)
26. Steinauer J, Pritts EA, Jackson R, Jacoby AF. Systematic review of mifepristone for the treatment of uterine leiomyomata. Obstet Gynecol 2004;103(6):1331-1336 (Pubitemid 40458970)
27. Ylikorkala O, Pekonen F. Naproxen reduces idiopathic but not fibromyoma-induced menorrhagia. Obstet Gynecol 1986;68(1): 10-12 (Pubitemid 16090829)
28. Schlaff WD, Zerhouni EA, Huth JA, Chen J, Damewood MD, Rock JA. A placebo-controlled trial of a depot gonadotropin-releasing hormone analogue (leuprolide) in the treatment of uterine leiomyomata. Obstet Gynecol 1989;74(6):856-862 (Pubitemid 20003274)
29. Nakayama H, Yano T, Sagara Y, et al. Estriol add-back therapy in the long-acting gonadotropin-releasing hormone agonist treatment of uterine leiomyomata. Gynecol Endocrinol 1999;13(6):382-389 (Pubitemid 30068311)
30. Palomba S, Affinito P, Tommaselli GA, Nappi C. A clinical trial of the effects of tibolone administered with gonadotropin-releasing hormone analogues for the treatment of uterine leiomyomata. Fertil Steril 1998;70(1):111-118 (Pubitemid 28294632)
31. Parker WH. Uterine myomas: management. Fertil Steril 2007;88(2):255-271
32. Lethaby A, Vollenhoven B, Sowter M. Efficacy of pre-operative gonadotrophin hormone releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy: a systematic review. BJOG 2002;109(10):1097-1108
33. Dubuisson JB. [How I perform... a laparoscopic myomectomy]. Gynecol Obstet Fertil 2006;34(6):526-528
34. Flierman PA, Oberye JJ, van der Hulst VP, de Blok S. Rapid reduction of leiomyoma volume during treatment with the GnRH antagonist ganirelix. BJOG 2005;112(5):638-642 (Pubitemid 40675802)
35. Cravello L. [Indications and modalities of surgical treatment for sub-mucosal myomas]. J Gynecol Obstet Biol Reprod (Paris) 1999;28(7):748-752
36. Cravello L, Farnarier J, Roger V, D'Ercole C, Blanc B. [Hysteroscopic myomectomy. Functional results with an average follow-up of 6 years]. J Gynecol Obstet Biol Reprod (Paris) 1998;27(6):593-597
37. Emanuel MH, Wamsteker K, Hart AA, Metz G, Lammes FB. Long-term results of hysteroscopic myomectomy for abnormal uterine bleeding. Obstet Gynecol 1999;93(5 Pt 1):743-748 (Pubitemid 29190674)
38. Somigliana E, Vercellini P, Daguati R, Pasin R, De Giorgi O, Crosignani PG. Fibroids and female reproduction: a critical analysis of the evidence. Hum Reprod Update 2007;13(5):465-476 (Pubitemid 47299852)
39. Varasteh NN, Neuwirth RS, Levin B, Keltz MD. Pregnancy rates after hysteroscopic polypectomy and myomectomy in infertile women. Obstet Gynecol 1999;94(2):168-171 (Pubitemid 29352855)
40. Chapron C, Fernandez B, Fauconnier A, Dubuisson JB. [Indications and modalities of conservative surgical treatment of interstitial and sub-serous myomas]. J Gynecol Obstet Biol Reprod (Paris) 1999;28(7):732-737
41. Mais V, Ajossa S, Guerriero S, Mascia M, Solla E, Melis GB. Laparoscopic versus abdominal myomectomy: a prospective, randomized trial to evaluate benefits in early outcome. Am J Obstet Gynecol 1996;174(2):654-658 (Pubitemid 26070160)
42. Sizzi O, Rossetti A, Malzoni M, et al. Italian multicenter study on complications of laparoscopic myomectomy. J Minim Invasive Gynecol 2007;14(4):453-462 (Pubitemid 47042613)
43. Diamond MP. Reduction of adhesions after uterine myomectomy by Seprafilm membrane (HAL-F): a blinded, prospective, randomized, multicenter clinical study. Seprafilm Adhesion Study Group. Fertil Steril 1996;66(6):904-910
44. Mais V, Ajossa S, Piras B, Guerriero S, Marongiu D, Melis GB. Prevention of de-novo adhesion formation after laparoscopic myomectomy: a randomized trial to evaluate the effectiveness of an oxidized regenerated cellulose absorbable barrier. Hum Reprod 1995;10(12):3133-3135 (Pubitemid 26026509)
45. Goodwin SC, Spies JB, Worthington-Kirsch R, et al. Uterine artery embolization for treatment of leiomyomata: long-term outcomes from the FIBROID Registry. Obstet Gynecol 2008;111(1):22-33.
46. Mara M, Fucikova Z, Maskova J, Kuzel D, Haakova L. Uterine fibroid embolization versus myomectomy in women wishing to preserve fertility: preliminary results of a randomized controlled trial. Eur J Obstet Gynecol Reprod Biol 2006;126(2):226-233 (Pubitemid 43786298)
47. Mara M, Maskova J, Fucikova Z, Kuzel D, Belsan T, Sosna O. Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovasc Intervent Radiol 2008;31(1):73-85.
48. Pron G, Mocarski E, Bennett J, Vilos G, Common A, Vanderburgh L. Pregnancy after uterine artery embolization for leiomyomata: the Ontario multicenter trial. Obstet Gynecol 2005;105(1):67-76. (Pubitemid 40189913)
49. SOGC clinical practice guidelines. Uterine fibroid embolization (UFE). Number 150, October 2004. Int J Gynaecol Obstet 2005;89(3):305-318
50. Fernandez H, Donnadieu AC. [Adenomyosis]. J Gynecol Obstet Biol Reprod (Paris) 2007;36(2):179-185
51. Fedele L, Bianchi S, Raffaelli R, Portuese A, Dorta M. Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device. Fertil Steril 1997;68(3):426-429 (Pubitemid 27412906)
52. Cho S, Nam A, Kim H, et al. Clinical effects of the levonorgestrel- releasing intrauterine device in patients with adenomyosis. Am J Obstet Gynecol 2008;198(4):373 e1-7.
53. Cooper KG, Parkin DE, Garratt AM, Grant AM. A randomised comparison of medical and hysteroscopic management in women consulting a gynaecologist for treatment of heavy menstrual loss. Br J Obstet Gynaecol 1997;104(12):1360-1366
54. Marjoribanks J, Lethaby A, Farquhar C. Surgery versus medical therapy for heavy menstrual bleeding. Cochrane Database Syst Rev 2006;19(2):CD003855.
55. Clegg JP, Guest JF, Hurskainen R. Cost-utility of levonorgestrel intrauterine system compared with hysterectomy and second generation endometrial ablative techniques in managing patients with menorrhagia in the UK. Curr Med Res Opin 2007;23(7):1637-1648 (Pubitemid 47122173)
56. Lethaby A, Hickey M, Garry R. Endometrial destruction techniques for heavy menstrual bleeding. Cochrane Database Syst Rev 2005;19(4):CD001501.
57. Kuppermann M, Varner RE, Summitt RL, Jr., et al. Effect of hysterectomy vs medical treatment on health-related quality of life and sexual functioning: the medicine or surgery (Ms) randomized trial. Jama 2004;291(12):1447-1455 (Pubitemid 38543735)
58. Hurskainen R, Teperi J, Rissanen P, et al. Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up. Jama 2004;291(12):1456-1463 (Pubitemid 38543736)
59. Lethaby A, Shepperd S, Cooke I, Farquhar C. Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding. Cochrane Database Syst Rev 2000;2(2):CD000329.
60. Dickersin K, Munro MG, Clark M, et al. Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding: a randomized controlled trial. Obstet Gynecol 2007;110(6):1279-1289 (Pubitemid 351326070)
61. Bahamondes L, Ribeiro-Huguet P, de Andrade KC, Leon-Martins O, Petta CA. Levonorgestrel-releasing intrauterine system (Mirena) as a therapy for endometrial hyperplasia and carcinoma. Acta Obstet Gynecol Scand 2003;82(6):580-582 (Pubitemid 36750713)
62. De Aloysio D, Altieri P, Pretolani G, Romeo A, Paltrinieri F. The combined effect of a GnRH analog in premenopause plus post-menopausal estrogen deficiency for the treatment of uterine leiomyomas in perimenopausal women. Gynecol Obstet Invest 1995;39(2):115-119
63. Loffer FD. Improving results of hysteroscopic submucosal myomectomy for menorrhagia by concomitant endometrial ablation. J Minim Invasive Gynecol 2005;12(3):254-260
64. Rosenbaum SP, Fried M, Munro MG. Endometrial hydrothermablation: a comparison of short-term clinical effectiveness in patients with normal endometrial cavities and those with intracavitary pathology. J Minim Invasive Gynecol 2005;12(2):144-149 (Pubitemid 40800369)
65. Gupta JK, Sinha AS, Lumsden MA, Hickey M. Uterine artery embolization for symptomatic uterine fibroids. Cochrane Database Syst Rev 2006;25(1):CD005073.
66. Razavi MK, Hwang G, Jahed A, Modanloo S, Chen B. Abdominal myomectomy versus uterine fibroid embolization in the treatment of symptomatic uterine leiomyomas. AJR Am J Roentgenol 2003;180(6):1571-1575 (Pubitemid 36687088)
67. Broder MS, Goodwin S, Chen G, et al. Comparison of long-term outcomes of myomectomy and uterine artery embolization. Obstet Gynecol 2002;100(5 Pt 1):864-868 (Pubitemid 35387451)
68. Hirst A, Dutton S, Wu O, et al. A multi-centre retrospective cohort study comparing the efficacy, safety and cost-effectiveness of hysterectomy and uterine artery embolisation for the treatment of symptomatic uterine fibroids. The HOPEFUL study. Health Technol Assess 2008;12(5):1-248.
69. Sawin SW, Pilevsky ND, Berlin JA, Barnhart KT. Comparability of perioperative morbidity between abdominal myomectomy and hysterectomy for women with uterine leiomyomas. Am J Obstet Gynecol 2000;183(6):1448-1455
70. Pelage JP, Jacob D, Fazel A, et al. Midterm results of uterine artery embolization for symptomatic adenomyosis: initial experience. Radiology 2005;234(3):948-953 (Pubitemid 40250842)
71. McCausland AM, McCausland VM. Depth of endometrial penetration in adenomyosis helps determine outcome of rollerball ablation. Am J Obstet Gynecol 1996;174(6):1786-93; 93-94
72. Raiga J, Bowen J, Glowaczower E, et al. [Failure factors in endometrial resection. 196 cases]. J Gynecol Obstet Biol Reprod (Paris) 1994;23(3):274-278
73. Maia H, Jr., Maltez A, Coelho G, Athayde C, Coutinho EM. Insertion of mirena after endometrial resection in patients with adenomyosis. J Am Assoc Gynecol Laparosc 2003;10(4):512-516 (Pubitemid 38020606)
74. Wood C. Surgical and medical treatment of adenomyosis. Hum Reprod Update 1998;4(4):323-336
75. DeVore GR, Owens O, Kase N. Use of intravenous Premarin in the treatment of dysfunctional uterine bleeding--a double-blind randomized control study. Obstet Gynecol 1982;59(3):285-291 (Pubitemid 12176943)
76. Aksu F, Madazli R, Budak E, Cepni I, Benian A. High-dose medroxyprogesterone acetate for the treatment of dysfunctional uterine bleeding in 24 adolescents. Aust N Z J Obstet Gynaecol 1997;37(2):228-231 (Pubitemid 27229089)
77. Munro MG, Mainor N, Basu R, Brisinger M, Barreda L. Oral medroxyprogesterone acetate and combination oral contraceptives for acute uterine bleeding: a randomized controlled trial. Obstet Gynecol 2006;108(4):924-929 (Pubitemid 44498254)
78. Goldrath MH. Uterine tamponade for the control of acute uterine bleeding. Am J Obstet Gynecol 1983;147(8):869-872
79. Nilsson L, Rybo G. Treatment of menorrhagia. Am J Obstet Gynecol 1971;110(5):713-720
80. Richards SR. Endometrial ablation for life-threatening abnormal uterine bleeding. A report of two cases. J Reprod Med 1994;39(9):741-742
81. Phelan JT, 2nd, Broder J, Kouides PA. Near-fatal uterine hemorrhage during induction chemotherapy for acute myeloid leukemia: a case report of bilateral uterine artery embolization. Am J Hematol 2004;77(2):151-155
82. Claessens EA, Cowell CA. Acute adolescent menorrhagia. Am J Obstet Gynecol 1981;139(3):277-280